Opendata, web and dolomites

ICA-100

A NOVEL NON-INVASIVE SOLUTION FOR CONTINUOUS BLOOD PRESSURE MONITORING

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ICA-100 project word cloud

Explore the words cloud of the ICA-100 project. It provides you a very rough idea of what is the project "ICA-100" about.

unstable    performance    commercialise    periodic    regulatory    gold    certified    continuous    none    regarding    volunteers    granting    icaria    intensive    influence    feasibility    movements    completing    massive    frequent    poses    purpose    positive    critical    besides    read    financial    accuracy    hospital    hyper    recalibrations    undertaken    655m    regarded    freedom    episodes    validated    risks    diastolic    deployment    solution    complications    poor    solutions    hitherto    units    healthy    mercury    catheter    serious    hypo    line    limited    operate    obtaining    hemodynamically    monitor    standard    monitoring    device    patient    limitations    framework    arterial    despite    pressure    attempts    care    international    systolic    technique    frame    sphygmomanometers    patents    decades    thoroughly    blood    effect    tension    patients    ica    invasive    severe    3b    follow    market    capability    plan    accurate    relative    icu    simplicity    hypertensive    trl5    obvious    ing    tracking    obstacles    strategy    marketing    individuals    protected   

Project "ICA-100" data sheet

The following table provides information about the project.

Coordinator
ICARIA MEDICAL S.L. 

Organization address
address: PZ PAU VILA, 1 PLANTA 2, PUERTA 2C EDIFICI PALAU DE MAR 2C
city: BARCELONA
postcode: 8039
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://www.icariamed.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ICARIA MEDICAL S.L. ES (BARCELONA) coordinator 50˙000.00

Map

 Project objective

Blood pressure follow-up is essential in managing hemodynamically unstable patients at Intensive Care Units (ICU). Traditionally, mercury sphygmomanometers have been used for this purpose, and are regarded as the gold standard for Blood Pressure measurement. Despite the relative simplicity of the technique, sphygmomanometers have obvious limitations regarding accuracy and tracking capability, especially crucial for hospital patients. In the most critical patients the invasive arterial line catheter must be used, which however poses serious risks for severe complications. Over the past decades, several attempts have been undertaken to develop an effective, accurate and reliable solutions to continuously monitor blood pressure in a non-invasive way. Hitherto, none of the solutions under development have achieved a massive market deployment. Major obstacles for the implementation of state-of-the-art solutions are related to their limited performance, resulting in poor accuracy in hypo/hyper tension episodes, influence of patient movements on the system response, and need for periodic and frequent recalibrations. ICARIA has developed a solution for blood pressure monitoring (ICA-100) based on a novel operating principle that allows obtaining an accurate diastolic and systolic Blood Pressure read-out. The ICA-100 has already been validated in healthy volunteers (TRL5). The technology is protected by two international patents, granting ICARIA freedom-to-operate. In the frame of this Phase 1 Project we aim to further develop our marketing strategy and financial plan. Besides, we aim to assess thoroughly the relevant regulatory and legal framework for the Project. After completing this feasibility study, we plan to develop and commercialise a certified device for Continuous Non-Invasive Blood Pressure monitoring. Having a positive impact in 655m hospital patients and a potential favourable effect on 1.3b hypertensive individuals, from which only 1 in 5 is under control.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ICA-100" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ICA-100" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More  

RDNA (2019)

Empowering New Venture Growth - RDNA

Read More  

COUNTMITMENT (2019)

NATURAL CAPITAL ACCOUNTANCY TO IMPROVE REPORTING AND ENVIRONMENTAL PERFORMANCE

Read More